Geovax Labs Inc (GOVX)
1.855
+0.06
(+3.06%)
USD |
NASDAQ |
Nov 05, 14:31
Geovax Labs Free Cash Flow: -23.00M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -23.00M |
| March 31, 2024 | -27.09M |
| December 31, 2023 | -25.22M |
| September 30, 2023 | -21.99M |
| June 30, 2023 | -20.74M |
| March 31, 2023 | -18.53M |
| December 31, 2022 | -19.16M |
| September 30, 2022 | -18.78M |
| June 30, 2022 | -16.59M |
| March 31, 2022 | -14.02M |
| December 31, 2021 | -11.24M |
| September 30, 2021 | -6.257M |
| June 30, 2021 | -4.881M |
| March 31, 2021 | -4.170M |
| December 31, 2020 | -2.907M |
| September 30, 2020 | -1.495M |
| June 30, 2020 | -1.554M |
| March 31, 2020 | -1.443M |
| December 31, 2019 | -1.406M |
| September 30, 2019 | -1.624M |
| June 30, 2019 | -1.559M |
| March 31, 2019 | -1.483M |
| December 31, 2018 | -1.543M |
| September 30, 2018 | -1.490M |
| June 30, 2018 | -1.689M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.738M |
| December 31, 2017 | -1.693M |
| September 30, 2017 | -1.613M |
| June 30, 2017 | -1.537M |
| March 31, 2017 | -1.654M |
| December 31, 2016 | -1.946M |
| September 30, 2016 | -2.338M |
| June 30, 2016 | -2.590M |
| March 31, 2016 | -2.715M |
| December 31, 2015 | -2.721M |
| September 30, 2015 | -2.594M |
| June 30, 2015 | -2.449M |
| March 31, 2015 | -2.417M |
| December 31, 2014 | -2.286M |
| September 30, 2014 | -2.474M |
| June 30, 2014 | -2.125M |
| March 31, 2014 | -1.940M |
| December 31, 2013 | -1.781M |
| September 30, 2013 | -1.506M |
| June 30, 2013 | -1.579M |
| March 31, 2013 | -1.549M |
| December 31, 2012 | -2.441M |
| September 30, 2012 | -1.684M |
| June 30, 2012 | -1.553M |
| March 31, 2012 | -1.003M |
Free Cash Flow Range, Past 5 Years
-27.09M
Minimum
Mar 2024
-1.406M
Maximum
Dec 2019
-12.66M
Average
-14.02M
Median
Mar 2022
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | 37.60M |
| Tonix Pharmaceuticals Holding Corp | -75.58M |
| Abbott Laboratories | 6.486B |
| SIGA Technologies Inc | 73.77M |
| Chimerix Inc | -67.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.941M |
| Cash from Financing (Quarterly) | 2.734M |
| Free Cash Flow Per Share (Quarterly) | -0.7642 |
| Free Cash Flow to Equity (Quarterly) | -2.083M |
| Free Cash Flow Yield | -572.9% |